| dbo:abstract
|
- Thomas Roland Insel, né le 19 octobre 1951 à Dayton en Ohio, est un neuroscientifique et un psychiatre américain. Il dirige le National Institute of Mental Health (NIMH) depuis 2002. Avant d'occuper ce poste, il était directeur du Center for Behavioral Neuroscience de l'université Emory à Atlanta en Géorgie, aux États-Unis. En neurosciences, il a surtout fait des recherches sur l'ocytocine et la vasopressine, deux hormones peptidiques qui régulent les comportements sociaux dits complexes, tels les soins parentaux et l'attachement. Il s'est aussi fait remarquer pour ses critiques sur le DSM-V (fr)
- Thomas Roland Insel (born October 19, 1951) is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X (now Verily Life Sciences). On May 8, 2017, CNBC reported that he had left Verily Life Sciences. Insel is a Co-founder with Richard Klausner and Paul Dagum of a digital mental health company named "Mindstrong," a Bay-area startup. He has also co-founded Humanest Care, NeuraWell Therapeutics, and MindSite News and is a member of the scientific advisory board for Compass Pathways, a company that is developing the psychedelic drug psilocybin to treat depression and other mental health disorders. His book, Healing: Our Path from Mental Illness to Mental Health was published by Penguin Random House in February, 2022. (en)
- トーマス・ローランド・インセル（Thomas Roland Insel、1951年10月19日 - ）は、アメリカの神経科学者ならびに精神科医であり、2002年以降(NIMH)を率いてきた。2015年までである。NIMH所長になるのに先立って、彼はジョージア州アトランタにあるエモリー大学の行動神経科学センターの所長を務めた。 彼は、親による世話と愛着のような、複雑な社会的行動に関与する2つのペプチドホルモン、オキシトシンとバソプレッシンについての研究で最もよく知られている。 (ja)
|
| dbo:almaMater
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:knownFor
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 16065 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:footnotes
| |
| dbp:imageSize
| |
| dbp:knownFor
|
- Research on oxytocin and vasopressin and their impact on social behavior (en)
|
| dbp:name
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitution
| |
| dcterms:subject
| |
| gold:hypernym
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- Thomas Roland Insel, né le 19 octobre 1951 à Dayton en Ohio, est un neuroscientifique et un psychiatre américain. Il dirige le National Institute of Mental Health (NIMH) depuis 2002. Avant d'occuper ce poste, il était directeur du Center for Behavioral Neuroscience de l'université Emory à Atlanta en Géorgie, aux États-Unis. En neurosciences, il a surtout fait des recherches sur l'ocytocine et la vasopressine, deux hormones peptidiques qui régulent les comportements sociaux dits complexes, tels les soins parentaux et l'attachement. Il s'est aussi fait remarquer pour ses critiques sur le DSM-V (fr)
- トーマス・ローランド・インセル（Thomas Roland Insel、1951年10月19日 - ）は、アメリカの神経科学者ならびに精神科医であり、2002年以降(NIMH)を率いてきた。2015年までである。NIMH所長になるのに先立って、彼はジョージア州アトランタにあるエモリー大学の行動神経科学センターの所長を務めた。 彼は、親による世話と愛着のような、複雑な社会的行動に関与する2つのペプチドホルモン、オキシトシンとバソプレッシンについての研究で最もよく知られている。 (ja)
- Thomas Roland Insel (born October 19, 1951) is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X (now Verily Life Sciences). On May 8, 2017, CNBC reported that he had left Verily Life Sciences. Insel is a Co-founder with Richard Klausner and Paul Dagum of a digit (en)
|
| rdfs:label
|
- Thomas R. Insel (fr)
- トーマス・インセル (ja)
- Thomas R. Insel (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:footnotes
of | |
| is foaf:primaryTopic
of | |
